• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Market Market
Market News
Market Stocks
  • Market Market
  • Market News
  • Market Stocks
cannabis investing

Mettrum to Sell Non-Core Subsidiary for $7 Million and Enters Three Year Product Supply Agreement

Matthew Spizziri
Sep. 20, 2016 10:20AM PST
Market News

Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products, is pleased to announce that it has entered into an agreement with Cannabis Care Canada Inc. (“CCC”) to sell to CCC its wholly-owned subsidiary Mettrum (Bennett North) Ltd. (“Bennett Road North”), which is licensed to produce and sell dried cannabis and cannabis extracts for medical purposes.

Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products, is pleased to announce that it has entered into an agreement with Cannabis Care Canada Inc. (“CCC”) to sell to CCC its wholly-owned subsidiary Mettrum (Bennett North) Ltd. (“Bennett Road North”), which is licensed to produce and sell dried cannabis and cannabis extracts for medical purposes. CCC is financially backed by Laborers International Union of North America (“LiUNA”), North America’s single largest construction union with over 100,000 Canadian members. Under the terms of the agreement, CCC will pay $7 million in cash to acquire Bennett Road North and enter into a three-year Supply Agreement that is expected to generate up to $40mm in revenue for Mettrum over the next three years. As part of the transaction, CCC will assume all outstanding obligations associated with Bennett Road North.
Once the transaction is completed in the coming months, Bennett Road North will be renamed Starseed Medicinal Inc. (“Starseed”) and will become a wholly-owned subsidiary of CCC, whose board members include Mr. G. Edmund King (former CEO and Chairman of Wood Gundy), Dr. Hugh E. Scully (previously president of both the Ontario and Canadian Medical Associations), and retired Major General Lewis Mackenzie. Mettrum will supply Starseed with cannabis and cannabis extracts to sell to members of LiUNA who have valid medical documents to use cannabis for medical purposes.
Highlights:

  • Supply Agreement Expected to Generate up to $40mm in Revenue and Make a Material Contribution to Profitability
  • Sale Agreement of Non-Core Asset adds Non-Dilutive $7mm to Balance Sheet
  • Accelerates Previously Announced Consolidation, Improving Operating Performance

“Given the scale of our operations at Bennett Road South and Creemore, it was very timely to find a purchaser for Bennett Road North who is also a great strategic partner,” said Michael Haines, Chief Executive Officer of Mettrum. “We are extremely excited to enter into this agreement which does three important things for Mettrum. First, it allows us to continue to lower operating costs by streamlining and consolidating our operations at our new headquarters. Second, it strengthens our already robust balance sheet in a non-dilutive manner. Lastly, and most importantly, it greatly enhances the scale of our business through our supply agreement, and access to a new market, with Cannabis Care Canada Inc.”
Laborers International Union of North America (“LiUNA”), North America’s single largest construction union with over 100,000 Canadian members, is a shareholder of Cannabis Care Canada Inc. and will be working closely with Starseed on behalf of its members. Mr. Joseph Mancinelli, VP of LiUNA said, “We believe cannabis is a medicine able to treat many ailments, including the management of pain. Working in conjunction with Mettrum and Starseed, we want to make medicinal cannabis treatment available to all of our members and their families and will, in time, make it a paid benefit.”
Connect with Mettrum Health Corp. (TSXV:MT.V) to receive an Investor Presentation.

cannabis investing canada mettrum health mettrum health corp
The Conversation (0)

Go Deeper

AI Powered
Cannabis Investing

MYM Nutraceuticals CEO: MYM More than Just a Cannabis Grower

Cannabis Weekly Round-Up: Shake Up for Canada’s Retail Market

Cannabis Weekly Round-Up: Shake Up for Canada’s Retail Market

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Stocks

extractX

extractX (None)
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES